Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Awakn Life Sciences Corp C.AWKN

Alternate Symbol(s):  AWKNF

Awakn Life Sciences Corp. is a Canada-based clinical-stage biotechnology company. The Company is developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Disorder (AUD). The Company's therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than the traditional single drug receptor targets. The Company... see more

CSE:AWKN - Post Discussion

Awakn Life Sciences Corp > AWKN Featured News 6/15/22: Pioneering Psychedelic Therapies
View:
Post by BullishPicks on Jun 15, 2022 10:58am

AWKN Featured News 6/15/22: Pioneering Psychedelic Therapies

Awakn Life Sciences Corp (OTCQB:AWKNF/ NEO:AWKN) Pioneering Psychedelic Therapies to treat AUD

https://stockifymedia.com/awakn-life-sciences-corp-otcqbawknf-neoawkn-pioneering-psychedelic-therapies-to-treat-aud-2/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities